内分泌病理学 SCIE

期刊简介预计审稿时间： 12周，或约稿

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.

《内分泌病理学》发表关于内分泌疾病临床和基础方面的原创文章。如果与人类正常或异常内分泌学相关，则可接受动物或体外技术研究。稿件将以原创文章、病例报告、临床病例陈述、评论和技术描述的形式考虑发表。提交论文意味着它报告了未发表的作品（摘要形式除外），并且不会同时提交给其他出版物。接受的稿件将成为《内分泌病理学》的唯一财产，未经出版商书面同意不得在其他地方发表。所有文章均需经过经验丰富的审稿人的审查。编辑和编辑委员会判断稿件是否适合发表，编辑的决定为最终决定。

《Endocrine Pathology》(内分泌病理学)编辑部通讯方式为HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。